肿瘤药学2016，Vol.6Issue(1)：4-10,7.DOI:10.3969/j.issn.2095-1264.2016.01.02
头颈部鳞癌的综合治疗进展
Recent Advances in the Management of HNSCC
李芳 1朱跃红1
作者信息
- 1. 湖南省肿瘤医院/中南大学湘雅医学院附属肿瘤医院头颈肿瘤内科，湖南 长沙，410013
- 折叠
摘要
Abstract
Surgical management continues to be the standard care for many head and neck squamous cell carcinoma (HN-SCC). But for patients with advanced disease not amenable to surgical resection, variouss combinations of radiotherapy, surgery and systemic therapy are generally required. Concurrent chemoradiotherapy (CRT) is now recognized worldwide as a standard treatment option. Evidence has largely supported the use of CRT, but disease recurrence and treatment toxicity continue to be challenges with this treatment paradigm. To obtain improved outcomes and mitigate disease recurrence and treatment toxicity, new agents such as cetuximab and induction chemotherapy have been explored. This article is to review the recent advances in the management of HNSCC, including new developments in molecular biology and treatment.关键词
头颈部鳞癌/放射治疗/化疗/分子靶向治疗Key words
HNSCC/Radiotherapy/Chemotherapy/Molecularbiologyandtreatment分类
医药卫生引用本文复制引用
李芳,朱跃红..头颈部鳞癌的综合治疗进展[J].肿瘤药学,2016,6(1):4-10,7.
